Tumor-associated macrophages constitute 30% of the tumor mass in glioblastoma, favoring the transition to the M2 immunosuppressive phenotype which inhibits cluster of differentiation (CD) 41 and CD81 T-cell functions and induces regulatory T-cell differentiation. Here, CD81 is linked to neoplasm.